SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo
Sara Mainardi(The Netherlands Cancer Institute), Antonio Mulero‐Sánchez(The Netherlands Cancer Institute), Anirudh Prahallad(Novartis (Switzerland)), Giovanni Germano(Candiolo Cancer Institute), Astrid Bosma(The Netherlands Cancer Institute), Paul Krimpenfort(The Netherlands Cancer Institute), Cor Lieftink(The Netherlands Cancer Institute), Jeffrey Steinberg(The Netherlands Cancer Institute), Niels de Wit(The Netherlands Cancer Institute), Samuel Gonçalves-Ribeiro(Institut d'Investigació Biomédica de Bellvitge), Ernest Nadal(Institut Català d'Oncologia), Alberto Bardelli(Candiolo Cancer Institute), Alberto Villanueva(Institut d'Investigació Biomédica de Bellvitge), René Bernards(The Netherlands Cancer Institute)
Cited by 315Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis